Overview
Pathophysiology
When initiating anticoagulant therapy, it is essential to assess the patient's risk of bleeding.
When initiating anticoagulant therapy, it is essential to assess the patient's risk of bleeding. Key factors to evaluate include the presence of an active gastrointestinal (GI) ulcer, recent surgical procedures, any intracranial pathology, and thrombocytopenia. These conditions increase the likelihood of bleeding complications during anticoagulant treatment and must be carefully considered to ensure patient safety.